Status:
COMPLETED
Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
The Association of Rehabilitation Medicine in Manitoba
Conditions:
Spinal Cord Injury
Tetraplegia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
People with a spinal cord injury (SCI) characteristically have low levels of high-density lipoprotein-cholesterol (HDL-c; "good cholesterol") and high levels of low-density lipoprotein-cholesterol (LD...
Eligibility Criteria
Inclusion
- Having chronic tetraplegia (at least on year since injury)
- 18 years or older
- Having below normal fasting blood plasma levels of HDL-c (\<1 mmol/l)
Exclusion
- Currently taking omega-3 supplements
- Currently taking medications for abnormal cholesterol
- Having a heart attack or stroke in the past one year
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2017
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01896037
Start Date
July 1 2013
End Date
March 28 2017
Last Update
May 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A 1M4